In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

Macrophage-directed Therapies Summit 2020

Oct 27, 2021 - 02:00 PM - Oct 28, 02:00 PM
Hanson Wade
Online Event

ZIP: 00000

With the explosive excitement and clinical proof of concept utilizing CD47 approaches, 2020 is the year for macrophage development, as we witness greater interest and investment in new work on novel macrophage targets outside of CD47.

The Macrophage-directed Therapies Summit is focused on optimizing the potential of macrophage therapies, through direct utilization of cells or small molecule approaches to target and stimulate macrophage cells in vivo for oncological indications and beyond.

Join us virtually this October as the trailblazers of macrophage therapeutic development, from the likes of Carisma Therapeutics, Faron Pharmaceuticals, and Verseau Therapeutics come together to advance the fundamental understanding of macrophage biology, avoiding on-target toxicities and the emerging field of macrophage cellular immunotherapy.

Early booking and Academic discounts available - see website for more details.



[email protected]

+1 617 455 4188

Tickets: https://go.evvnt.com/653684-2?pid=1052
Brochure: https://go.evvnt.com/653684-3?pid=1052

Conference Only (Drug Developer Pricing) - DIGITAL : USD 2099.0,
Conference Only (Standard Pricing) - DIGITAL : USD 2449.0,
Conference Only (Academic Pricing) - DIGITAL : USD 1259.0

Speaker Details

Arun Kashyap, Vice President, Research, Arch Oncology, Sergio Trombetta, Senior Principal Scientist, Cancer Immunology and Immune Modulation, Boehringer Ingelheim, Michael Klichinsky, Co-Founder and VP, Discovery, Carisma Therapeutics, C. Wyatt Shields, IV Assistant Professor, Department of Chemical and Biological Engineering, University of Colorado Boulder, Juho Jalkanen, Chief Development Officer, Faron Pharmaceuticals, Dr. Nico Lachmann, Principle Investigator, Hannover Medical School, Jennifer Guerriero, Instructor in Medicine, Director, Harvard Medical School, Breast Tumor Immunology Laboratory, Dana- Farber Cancer Institute, Yaron Pereg, Chief Executive Officer, Kahr Medical, Mable Wing Yan Chan, PhD Candidate, Arthritis Program, Krembil Research Institute, University Health Network, Institute of Biomaterials and Biomedical Engineering, University of Toronto, Venkat Reddy, Chief Scientific Officer, Macrophage Pharma, Jeffrey Pollard, Director, Professor of Resilience Biology, Medical Research Council Centre for Reproductive Health, University of Edinburgh, Hung-Yen (Peter) Chou, Scientist, Oncoimmune, Yang Liu Founder, President and Chief Scientific Officer, Oncoimmune, Nicolas Poirier, Chief Scientific Officer, OSE Immunotherapeutics, Leonard Reyno, Chief Executive Officer, Pionyr Immunotherapeutics, Emmanuel Normant, VP Preclinical Sciences, TG Therapeutics, Gloria Lin, Associate Director of Translational Research, Trillium Therapeutics Inc., Bruce C. Trapnell, Professor of Medicine and Pediatrics, Director, University of Cincinnati College of Medicine, Translational Pulmonary Science Center, Cincinnati Children’s Hospital, Sowmya Viswanathan, Assistant Professor, Institute of Biomaterial and Biomedical Engineering, Scientist, University of Toronto, Krembil Research Institute, University Health Network, Dartha Puttta, Assistant Professor, University of Pittsburgh, Ashish Kulkarni, Assistant Professor of Chemical Engineering, University of Massachusetts Amherst, Igor Feldman, Vice President, Head of Computational Biology, Verseau Therapeutics, Tatiana Novobrantseva, Co-founder and Chief Scientific Officer, Verseau Therapeutics

Event Categories
Keywords: conference , pharmaceutical


Events Calendar

26 27 28 29 30 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 1 2 3 4 5 6


VIP Life Time Subscription to our Newsletters!